Literature DB >> 16874070

The two faces of autophagy: Coxiella and Mycobacterium.

María Isabel Colombo1, Maximiliano G Gutierrez, Patricia S Romano.   

Abstract

In the world of pathogen-host cell interactions, the autophagic pathway has been recently described as a component of the innate immune response against intracellular microorganisms. Indeed, some bacterial survival mechanisms are hampered when this process is activated. Mycobacterium tuberculosis infection of macrophages, for example, is impaired upon autophagy induction and the bacterial phagosomes are redirected to autophagosomes. On the other hand, pathogens like Coxiella burnetii are benefited by this cellular response and subvert the autophagy process resulting in a more efficient replication. We study at the molecular level these two different faces of the autophagy process in pathogen life in order to elucidate the intricate routes modulated by the microorganisms as survival strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16874070     DOI: 10.4161/auto.2827

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  24 in total

1.  The early secretory pathway contributes to the growth of the Coxiella-replicative niche.

Authors:  Emanuel Martín Campoy; Felipe Carlos Martín Zoppino; María Isabel Colombo
Journal:  Infect Immun       Date:  2010-10-11       Impact factor: 3.441

2.  Arp2 links autophagic machinery with the actin cytoskeleton.

Authors:  Iryna Monastyrska; Congcong He; Jiefei Geng; Adam D Hoppe; Zhijian Li; Daniel J Klionsky
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

3.  The Atg1 kinase complex is involved in the regulation of protein recruitment to initiate sequestering vesicle formation for nonspecific autophagy in Saccharomyces cerevisiae.

Authors:  Heesun Cheong; Usha Nair; Jiefei Geng; Daniel J Klionsky
Journal:  Mol Biol Cell       Date:  2007-12-12       Impact factor: 4.138

4.  Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent Coxiella burnetii.

Authors:  Amanda L Dragan; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

5.  TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation.

Authors:  Paras K Anand; Stephen W G Tait; Mohamed Lamkanfi; Amal O Amer; Gabriel Nunez; Gilles Pagès; Jacques Pouysségur; Maureen A McGargill; Douglas R Green; Thirumala-Devi Kanneganti
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

Review 6.  Dining in: intracellular bacterial pathogen interplay with autophagy.

Authors:  Caylin G Winchell; Shaun Steele; Tom Kawula; Daniel E Voth
Journal:  Curr Opin Microbiol       Date:  2015-10-21       Impact factor: 7.934

7.  IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.

Authors:  Ana I Rovetta; Delfina Peña; Rodrigo E Hernández Del Pino; Gabriela M Recalde; Joaquín Pellegrini; Fabiana Bigi; Rosa M Musella; Domingo J Palmero; Marisa Gutierrez; María I Colombo; Verónica E García
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

8.  Proteinase protection of prApe1 as a tool to monitor Cvt vesicle/autophagosome biogenesis.

Authors:  Wei-Lien Yen; Daniel J Klionsky
Journal:  Autophagy       Date:  2012-06-01       Impact factor: 16.016

9.  Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.

Authors:  Svea Matthiesen; Luca Zaeck; Kati Franzke; Rico Jahnke; Charlie Fricke; Michael Mauermeir; Stefan Finke; Anja Lührmann; Michael R Knittler
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

10.  Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins.

Authors:  Munir A Al-Zeer; Hesham M Al-Younes; Daniel Lauster; Mohammad Abu Lubad; Thomas F Meyer
Journal:  Autophagy       Date:  2012-10-19       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.